CNS Pharmaceuticals (NASDAQ: CNSP) announced updated results from its ongoing pivotal trial evaluating Berubicin, a <a target=_blank href= ...

Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) has submitted a supplemental new drug application (SNDA) to the U.S. Food and ...

Berubicin is currently in development for the treatment of a number of serious brain and CNS oncology indications including glioblastoma multiforme (GBM), an aggressive and incurable form of brain ...

Virus. When you hear the word, you probably shudder. But not all viruses are bad or cause disease. Some are even used for ...

Cayman residents travelling this Christmas will enjoy double the usual duty free allowance on their shopping after Cabinet approved an Order under the Customs Tariff regulations, last week, ...

After hours: November 29 at 1:02 PM EST ...

A CNS may bill Medicare for a service provided ... under the physician's provider number (and Medicare would pay the full physician rate for that service) if the service: Would be covered if ...

MECP2 may have an ongoing and critical role in mature CNS neurons and only prolonged deficiency may lead to the neuronal dysfunction characteristic for the disease. If this is correct, therapeutic ...

CNS cancer is a type of cancer that forms in the central nervous system. It includes brain stem glioma, craniopharyngioma, medulloblastoma and meningioma. Metastatic spread of cancer to the brain ...